We analyzed the correlation of EZH2 and TOP2A with patients’ clinicopathological variables using HCC data from TCGA database and found that high EZH2 and TOP2A expression was significantly associated with tumor differentiation grade, tumor invasion, TNM stage, and the status of patients with HCC (Table 1). This evidence concerns the gene EZH2 and hepatocellular carcinoma.